ChondroFiller, a cartilage regeneration treatment, is available in Germany and was developed there. Specifically, Meidrix Biomedicals GmbH, based in Esslingen, Germany, manufactures and markets ChondroFiller liquid, an acellular collagen implant for treating cartilage defects. The product is CE-certified and manufactured under GMP conditions.
Here’s a more detailed breakdown:
- Developed in Germany:Meidrix Biomedicals, with its roots in Esslingen, Baden-Württemberg, developed ChondroFiller, including the liquid form.
- CE-certified and GMP:The product is CE-marked, indicating it meets European safety standards, and is produced under Good Manufacturing Practice (GMP) guidelines.
- Application:ChondroFiller is designed for arthroscopic treatment of cartilage defects in joints like the knee, hip, and shoulder.
- Availability:It’s sold in over 20 countries and is intended for rapid international expansion, according to BioSpace.
- Mechanism:ChondroFiller stimulates the body’s natural cartilage regeneration by providing a collagen matrix that cells can populate.
- Minimally Invasive:The liquid form allows for injection into the defect site using a two-chamber syringe, making it a minimally invasive procedure